GSE182680 GSE182683 dexamethasone 7 v 13 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE182680_GSE182683_dexamethasone_7_v_13_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE182680_GSE182683_dexamethasone_7_v_13_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE182680_GSE182683_dexamethasone_7_v_13_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE182680_GSE182683_dexamethasone_7_v_13_human_up.

Results found

Linked to

 

Label

Description

 

Gene

lysine demethylase 5D

Gene

TNF superfamily member 10

Gene

placenta associated 8

Gene

sortilin related receptor 1

Gene

serum/glucocorticoid regulated kinase 1

Gene

cyclin dependent kinase inhibitor 1A

Gene

phospholipase A and acyltransferase 3

Gene

thiol methyltransferase 1A

Gene

Rho related BTB domain containing 3

Gene

5'-nucleotidase ecto

  • Gene

    lysine demethylase 5D


  • Gene

    TNF superfamily member 10


  • Gene

    placenta associated 8


  • Gene

    sortilin related receptor 1


  • Gene

    serum/glucocorticoid regulated kinase 1


  • Gene

    cyclin dependent kinase inhibitor 1A


  • Gene

    phospholipase A and acyltransferase 3


  • Gene

    thiol methyltransferase 1A


  • Gene

    Rho related BTB domain containing 3


  • Gene

    5'-nucleotidase ecto

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.